Skip to main content
  1. Right Decisions
  2. GGC - Clinical Guideline Platform
  3. Maternity
  4. Back
  5. Antenatal, general
  6. Monitoring and Management of Suspected Fetal Growth Restriction (414)
Announcements and latest updates

Right Decision Service newsletter: September 2024

Welcome to the Right Decision Service (RDS) newsletter for September 2024.

1.Business case for permanent provision of the Right Decision Service from April 2025 onwards

This business case has now been endorsed by the HIS Board and will shortly be submitted to Scottish Government.

2. Management of RDS support tickets

To balance increasing demand with available capacity and financial resource, the RDS team and Tactuum are now working together to  implement closer management of support tickets. As a key part of this, we want to ensure clear, timely and consistent communication with yourselves as requesters.  

Editors will now start seeing new messages come through in response to support ticket requests which reflect this tightening up and improvement of our processes.

Key points to note are:

2.1 Issues confirmed by the RDS and Tactuum teams as meeting the critical/urgent and high priority criteria will continue to be prioritised and dealt with immediately.

Critical/urgent issues are defined as:

  1. The Service as a whole is not operational for multiple users. OR
  2. Multiple core functions of the Service are not operational for multiple users.

Example – RDS website outage.

Please remember to email ann.wales3@nhs.scot and his.decisionsupport@nhs.scot with any critical/urgent issues in addition to raising a support ticket.

High priority issues are defined as:

  1. A single core function of the Service is not operational for multiple users. OR:
  2. Multiple non-core functions of the Service are not operational for multiple users.

Example – Build to app not working.

2.2 Support requests that are outwith the warranty period of 12 weeks since the software was originally developed will not be automatically addressed by Tactuum. The RDS team will consider these requests for costed development work and will obtain estimate of effort and cost from Tactuum for priority issues.

2.3 Support tickets for technical issues that are not classified as bugs will not be automatically addressed by Tactuum. The definition of a bug is ‘a defect in the software that is at variance with documented user requirements.’  Issues that are not bugs will also be considered for costed development work.

The majority of issues currently in support tickets fall into category 2 or 3 above, or both.

2.4 Non-urgent requests that require a deployment (i.e a new release of RDS) will normally be factored into the next scheduled release (currently end of Nov 2024 and end of Feb 2025) unless by special agreement with the RDS team.

Please note that we plan to move in the new year to a new system whereby requests all come to an RDS support portal in the first instance and are triaged from there to Tactuum when appropriate.

We will be organising a webinar in a few weeks’ time to take you through the details of the current support processes and criteria.

3. Next scheduled deployment.

The next scheduled RDS deployment will take place at the end of November 2024.  We are reviewing all outstanding support tickets and feature requests along with estimates of effort and cost to determine which items will be included in this deployment.

We will update you on this in the next newsletter and in the planned webinar about support ticket processes.

4. Contingency arrangements for RDS

Many thanks to those of you who attended our recent webinar on the contingency arrangements being put in place to prevent future RDS outages as far as possible and minimise impact if they do occur.  Please contact ann.wales3@nhs.scot if you would like a copy of the slides from this session.

5. Transfer of CKP pathways to RDS

The NES clinical knowledge pathway (CKP) publisher is now retired and the majority of pathways supported by this tool have been transferred to the RDS. Examples include:

NHS Lothian musculoskeletal pathways

NHS Fife rehabilitation musculoskeletal pathways

NHS Tayside paediatric pathways

6. Other new RDS toolkits

Include:

Focus on frailty (from HIS Frailty improvement programme)

NHS GGC Money advice and support

If you would like to promote one of your new toolkits through this newsletter, please contact ann.wales3@nhs.scot

To go live imminently:

  • Focus on dementia
  • NHS Lothian infectious diseases toolkit
  • Dumfries and Galloway Adult Support and Protection procedures
  • SIGN guideline – Prevention and remission of type 2 diabetes

 

7. Evaluation projects

We have recently analysed the results of a survey of users of the Scottish Palliative Care Guidelines toolkit.  Key findings from 61 respondents include:

  • Most respondents (64%) are frequent users of the toolkit, using it either daily or weekly. A further 25% use it once or twice per month.
  • 5% of respondents use the toolkit to deliver direct patient care and 82% use it for learning
  • Impact on practice and decision-making was rated as very high, with 80% of respondents rating these at a 4-5 on a 5 point scale.
  • Impact on time saving was also high, with 74% of respondents rating it from 3-5.
  • 74% also reported that the toolkit improved their knowledge and skills, rating these at 4-5 on the Likert scale

Key strengths identified included:

  • The information is useful, succinct, and easy to understand (31%).
  • Coverage is comprehensive (15%)
  • All information is readily accessible in one place and users value the offline access via mobile app (15%)
  • Information is reliable, evidence-based and up to date (13%)

Users highlighted key areas for improvement in terms of navigation and search functionality. The survey was very valuable in enabling us to uncover the specific issues affecting the user experience. Many of these can be addressed through content management approaches. The issues identified with search results echo other user feedback, and we are costing improvements with a view to implementation in the next RDS deployment.

8.RDS High risk prescribing (polypharmacy) decision support embedded in Vision and EMIS primary care E H R systems

This decision support software, sponsored by Scottish Government Effective Prescribing and Therapeutics Division,  is now available for all primary care clinicians across NHS Tayside. Board-wide implementation is also planned for NHS Lothian, and NHS GGC, NHS Ayrshire and Arran and NHS Dumfries and Galloway have initial pilots in progress. The University of Dundee has been commissioned to evaluate impact of this decision support software on prescribing practice.

9. Video tutorials for RDS editors

Ten bite-size (5 mins or less) video tutorials for RDS editors are now available in the “Resources for providers of RDS tools” section of the RDS.  These cover core functionality including Save and preview, content page and media management, password management and much more.

10. Training sessions for new editors (also serve as refresher sessions for existing editors) will take place on the following dates:

  • Wednesday 23rd October 4-5 pm
  • Tuesday 29th October 11 am -12 pm

To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)

If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot  

With kind regards

 

Right Decision Service team

Healthcare Improvement Scotland

 

 

 

Monitoring and Management of Suspected Fetal Growth Restriction (414)

Warning

Please report any inaccuracies or issues with this guideline using our online form

 

 

Definitions

For the purposes of this guideline the following definitions apply:

Small for gestational age (SGA): Estimated fetal weight (EFW) or abdominal circumference (AC) <10th centile

Fetal growth restriction (FGR):  Where a fetus fails to reach its growth potential as adapted from the Delphi consensus:

Early Onset FGR <32wks

Late onset FGR ≥32wks

EFW or AC <3rd centile

Or Absent umbilical artery end diastolic flow (EDF)

Or EFW/AC <10th centile with at least one of:

  • Umbilical artery pulsatility index >95th centile or absent or reversed EDF
  • Uterine artery pulsatility index >95th centile

EFW <3rd centile

Or At least two of the following:

  • EFW <10th centile
  • EFW crossing ≥50 centiles
  • Umbilical artery pulsatility index >95th centile or absent or reversed EDF

This guideline does not apply to multiple pregnancies or babies with congenital abnormalities.

Estimated fetal weight should be used after 22+0wks as plotted on the Intergrowth chart on Badgernet. Prior to 22+0wks abdominal circumference should be used.

Identifying non-placental causes of FGR

Babies found to have an AC <3rd centile at the time of routine anomaly scan should be referred to a fetal medicine specialist within the unit. Serological screening for cytomegalovirus and toxoplasmosis should be offered along with invasive testing for full karyotype and microarray.

Monitoring of babies found to be SGA

The purpose of monitoring is to identify those babies suspected to have FGR and therefore at greater risk of adverse perinatal outcome. Birth timing balances risk of stillbirth against risk of prematurity including adverse outcomes associated with early term birth (37+0 - 38+6wks).

For babies identified as SGA with no features of FGR suitable surveillance is ultrasound every 2wks for biometry, umbilical artery doppler and liqor volume. In the absence of fetal or maternal compromise birth should be offered at 39+0wks. Examples of fetal or maternal compromise include hypertension, reduced fetal movements, reduced liqor volume or abnormal CTG.

Monitoring of babies identified as early onset FGR

For babies identified as early onset FGR, fetal biometry should be performed every 2wks with weekly liqor volume and umbilical artery doppler. If there is absent or reversed EDF prior to 32+0wks then twice weekly doppler should be performed and birth is indicated if the ductus venosus a wave is absent or reversed.

Cardiotocograph (CTG) can be performed from 26+0wks. If computerised CTG is available then short term variability (STV) should be used to guide birth timing. STV <2.6ms between 26+0 and 28+6wks or <3.0ms between 29+0 and 31+6wks indicates birth should be offered as does the presence of persistent unprovoked decelerations at any gestation. Frequency of CTG monitoring will be determined by the individual circumstances.

Monitoring of babies identified as late onset FGR

For babies identified as late onset FGR, fetal biometry should be performed every 2wks with weekly liqor volume and umbilical artery doppler. Middle cerebral artery doppler performed after 34wks gestation may guide timing of birth but further evidence is awaited on this.  

Frequency of CTG monitoring will depend on individual circumstances. If computerised CTG is available then birth is indicated if STV is <3.5ms between 32+0 and 33+6 or < 4.5ms at gestations >34wks, or in the presence of persistent unprovoked decelerations at any time.

Birth is indicated between 32+0 and 33+6wks if the umbilical artery EDF is reversed. Birth >34wks is indicated if umbilical artery EDF is absent or reversed. Early birth may also be indicated by other evidence of fetal compromise such as decreased liqor volume, maternal hypertension or reduced fetal movements.

If monitoring is reassuring then birth can be offered at 37wks for babies with suspected FGR.

Identifying babies with suboptimal growth

A proportion of babies who are growth restricted will not be SGA, particularly those presenting late in the third trimester.

Evidence of reduced growth velocity or “tailing growth”  is defined as a drop of 50 centiles  on sequential scanning for example a drop from the 70th to the 20th percentile. This should prompt further ultrasound in two weeks with birth offered at 37wks, earlier if there is evidence of fetal or maternal compromise as outlined above. If EFW falls below 10th centile or there are abnormal dopplers then ongoing monitoring and birth timing is as for late onset FGR babies.

Pathway

Algorithm for the monitoring and management of fetal growth restriction

Editorial Information

Last reviewed: 27/02/2024

Next review date: 08/02/2027

Author(s): Roseanna Metcalfe.

Version: 2

Approved By: Maternity Clinical Governance Group

Document Id: 414

Evidence method

Adapted from Saving Baby’s Lives Care Bundle V 3 (2023) and the ISUOG Practice Guideline on diagnosis and management of SGA fetus and FGR (2020)